These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33446000)

  • 1. Performance of a Predictive Model versus Prescription-Based Thresholds in Identifying Patients at Risk of Fatal Opioid Overdose.
    Ferris LM; Saloner B; Jackson K; Lyons BC; Murthy V; Kharrazi H; Latimore A; Stuart EA; Weiner JP
    Subst Use Misuse; 2021; 56(3):396-403. PubMed ID: 33446000
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data.
    Ferris LM; Saloner B; Krawczyk N; Schneider KE; Jarman MP; Jackson K; Lyons BC; Eisenberg MD; Richards TM; Lemke KW; Weiner JP
    Am J Prev Med; 2019 Dec; 57(6):e211-e217. PubMed ID: 31753274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of unsolicited reporting notifications on providers' prescribing behavior: An experimental study on Maryland PDMP data.
    Amin-Esmaeili M; Alinsky R; Johnson RM; Gribble A; Oyedele N; Parnham T; Goddard L; Susukida R
    Drug Alcohol Depend; 2023 Jul; 248():109896. PubMed ID: 37163865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data.
    Saloner B; Chang HY; Krawczyk N; Ferris L; Eisenberg M; Richards T; Lemke K; Schneider KE; Baier M; Weiner JP
    JAMA Psychiatry; 2020 Nov; 77(11):1155-1162. PubMed ID: 32579159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
    Young LD; Kreiner PW; Panas L
    Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.
    Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M
    Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).
    Agrawal R; Verma S; Halappanavar M
    Community Ment Health J; 2021 Jul; 57(5):920-925. PubMed ID: 32666418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids.
    Liang D; Shi Y
    Drug Alcohol Rev; 2019 Jul; 38(5):494-502. PubMed ID: 31317593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity.
    Brown R; Riley MR; Ulrich L; Kraly EP; Jenkins P; Krupa NL; Gadomski A
    Drug Alcohol Depend; 2017 Sep; 178():348-354. PubMed ID: 28692945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone related deaths compared to all prescription related deaths.
    Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
    Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysis.
    Ferris LM; Weiner JP; Saloner B; Kharrazi H
    JAMIA Open; 2022 Apr; 5(1):ooac020. PubMed ID: 35571361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018.
    Ball SJ; Simpson K; Zhang J; Marsden J; Heidari K; Moran WP; Mauldin PD; McCauley JL
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):379-384. PubMed ID: 32956292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription History Before Opioid Overdose Death: PDMP Data and Responsible Prescribing.
    Shreffler J; Shaw I; Berrones A; Huecker M
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):385-392. PubMed ID: 32810066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
    Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
    Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.